Denovo Biopharma

San Diego, United States

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.

Apr 2024

Grant

Biopharma Biotechnology Health Care

Top Investors

CICCCalifornia Institute for Regenerative MedicineChina Resources Pharmaceutical GroupYingke CapitalGuangzhou Yuexiu Industrial Investment Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Denovo Biopharma

Who are Denovo Biopharma's investors?

Denovo Biopharma's investors include CICC, California Institute for Regenerative Medicine, China Resources Pharmaceutical Group, Yingke Capital, Guangzhou Yuexiu Industrial Investment Fund.

Where is Denovo Biopharma headquartered?

Denovo Biopharma is headquartered in San Diego, United States.

What does Denovo Biopharma do?

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.

What stage is Denovo Biopharma at?

Denovo Biopharma is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2024.

MLA

"Denovo Biopharma — Funding & Investors." VCBacked, April 30, 2024, https://www.vcbacked.co/company/denovo-biopharma. Accessed July 1, 2026.

APA

VCBacked. (2024). Denovo Biopharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/denovo-biopharma

Wikipedia (cite web)

{{cite web |title=Denovo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/denovo-biopharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2024.